Pacemakers are electric activity generating devices which are used for the treatment of patients with slow heart rate, or symptomatic heart blocks and in patients with heart failure.[1] All cardiac pacemakers are generally composed of a pulse generator that generates the electrical current required for stimulation of heart musculature and one or two electrodes (also referred to as leads), which are responsible for transmitting the electrical activity generated by the pulse generator to the heart musculature.[2][3]
Common indications for pacemaker placement include:
Other less common indications include:
Following are the conditions in which cardiac pacing is not indicated:
PACEMAKER TYPES AND SYSTEMS:
Pulse Generators: These are the "battery" component of the pacemaker, which normally produces the electrical activity required to transmit to the heart musculature. Pulse generators are currently placed most commonly in the infraclavicular region of the anterior chest wall.
Trans venous Systems: Most of the cardiac pacing systems make use of the Transvenous electrodes for transmitting electrical impulses from the pulse generator to the heart musculature.
Epicardial systems: These work by the direct stimulation through the pulse generator by attaching directly to the surface of the heart. They are less common use nowadays, and transvenous pacing has completely replaced them.
Leadless systems: There have been some newer innovations to develop leadless systems due to some limitations with transvenous and epicardial pacing systems.[8][9][10]
Types of Pacemakers:
There are three basic kinds of pacemakers:
Modes of Cardiac Pacing:
The modes of pacemakers are based on generic code known as NBG ( combined from NASPE/BPEG) and typically consist of 5 letters.[11]
The modes are explainable by dividing them into categories of single chamber or dual chamber:
Single Chamber Modes
V- Pacing in the ventricle
O- Sensing is OFF
O- Response to sensing is OFF
In this mode, pacemaker paces at a programmed rate regardless of the intrinsic electrical activity of the heart.
V- Pacing in the ventricle
V- Sensing in the ventricle
I-Inhibit
In this mode, the pacemaker can sense the electrical activity and withhold pacing when not required.
A- Pacing in the atrium
O- Sensing is OFF
O- Response to sensing is OFF
In this mode, pacemaker paces at a programmed rate regardless of the intrinsic electrical activity of the heart.
A- Pacing in the atrium
A- Sensing in the atrium
I- Inhibit
If the patient is chronotropically incompetent, the mode of choice will be DDDR
If the patient is chronotropically competent, the mode of choice will be DDD.
In this mode, the pacemaker can adapt to the intrinsic atrial rate and should be able to pace when needed and inhibit when not required.
Dual Chamber Modes
Dual Chamber Modes can further subdivide into Tracking Modes and Non-Tracking modes.
Tracking Modes:
D- Pacing in the atrium and ventricle
D- Sensing in the atrium and ventricle
D- Inhibit and or trigger
Intrinsic P-wave and QRS can inhibit pacing, and intrinsic P-wave or atrial pace can trigger an AV delay.
This mode is fully capable of adapting to intrinsic heart rhythm and mimicking normal conduction as much as possible.
DDD has four distinct pacing patterns
V- Pacing in the ventricle
D- Sensing in the atrium and ventricle
D- Inhibit and or trigger
Intrinsic QRS can inhibit ventricular pacing, and Intrinsic P-wave can trigger an AV delay.
In this mode, one cannot pace the atrium, but an intrinsic atrial activity can trigger an AV delay resulting in P-wave tracking and possibly maintaining AV synchrony.
The primary issue with VDD programming mode is that if sinus node function drops below the pacemaker programmed lower rate, then it will cause AV dissociation due to the inability to pace in the atrium.
VDD mode should only be used in patients with good SA node function. Might be used in a situation where the patient has a high pacing threshold in the atrium. This way, the pacemaker will be able to sense in the atrium, maintain AV synchrony, and not waste battery life by pacing in the high threshold atrium.
Non-Tracking Modes
D - Pacing in the atrium and ventricle
D - Sensing in the atrium and ventricle
I - Response to that sensing will be to either pace or inhibit
This mode's primary use is in patients with atrial tachyarrhythmias and mode switch algorithms. DDI mode will result in AV dissociation if the atrial rate goes high than the set rate. P wave tracking is excellent for AV synchrony; however, if the patient goes into atrial fibrillation with rapid heart rate, one does not want to track atrium and pace the ventricle at a high rate.
D- Pacing in the atrium and ventricle
O- Sensing is OFF
O- Response to that sensing is OFF
This mode results in AV sequential pacing at the lower rate limit regardless of the heart's own intrinsic activity. DOO mode is asynchronous pacing and usually used only in certain situations, such as when a magnet is placed over a pacemaker or sometimes when a patient is having surgery.
R- Rate Response
Rate Response or Rate Adaptive Pacing is used in patients with chronotropic incompetence. Chronotropic incompetence is defined as the inability of the heart to appropriately increase its rate with increased activity or metabolic demand that leads to exercise intolerance. Usually, there is a problem in SA node function.
The pacemaker utilizes its sensing ability with the aid of sensors that can sense motion or minute ventilation changes according to the activity and pace the heart at a required rate.
Choosing a Pacing Mode:
While selecting a pacemaker mode, the clinician will want to make sure that the patient has a viable atrial activity. If the atrium is healthy, the clinician will want to maintain AV synchrony as much as possible.
The first important question is if the sinus node function is intact?
If sinus node function is not intact and the patient has atrial arrhythmias:
Chronic Atrial Arrhythmias, e.g., Atrial Fibrillation or Atrial Flutter:
Paroxysmal Atrial Arrhythmias:
If the sinus node is intact and the patient has normal sinus rhythm or sinus bradycardia:
Intact AV Node conduction
AV Node conduction not Intact:
Pacemakers are implanted in situations when the intrinsic electrical activity of the heart is either dyssynchronous, and the patient is having symptomatic episodes resulting from the asynchronous electrical impulse stimulated from the SA node. Different pacemaker types and modes as mentioned above are available, and a deep and close monitoring and understanding of these modes and close-loop monitoring by the inter-professional team is of utmost importance in the management of patients with cardiac pacemakers.
Pacemaker Related Complications:
Pacemaker Syndrome: Pacemaker syndrome is a disease that represents the clinical consequences of suboptimal atrioventricular (AV) synchrony or AV dyssynchrony, regardless of the pacing mode after pacemaker implantation.
Symptoms of Pacemaker Syndrome are:
Other complications associated with Pacemakers include:
[1] | Kusumoto FM,Schoenfeld MH,Barrett C,Edgerton JR,Ellenbogen KA,Gold MR,Goldschlager NF,Hamilton RM,Joglar JA,Kim RJ,Lee R,Marine JE,McLeod CJ,Oken KR,Patton KK,Pellegrini CN,Selzman KA,Thompson A,Varosy PD, 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Journal of the American College of Cardiology. 2019 Aug 20; [PubMed PMID: 30412709] |
[2] | Nelson GD, A brief history of cardiac pacing. Texas Heart Institute journal. 1993; [PubMed PMID: 8508058] |
[3] | Verma N,Knight BP, Update in Cardiac Pacing. Arrhythmia [PubMed PMID: 31463061] |
[4] | Brignole M,Auricchio A,Baron-Esquivias G,Bordachar P,Boriani G,Breithardt OA,Cleland J,Deharo JC,Delgado V,Elliott PM,Gorenek B,Israel CW,Leclercq C,Linde C,Mont L,Padeletti L,Sutton R,Vardas PE,Zamorano JL,Achenbach S,Baumgartner H,Bax JJ,Bueno H,Dean V,Deaton C,Erol C,Fagard R,Ferrari R,Hasdai D,Hoes AW,Kirchhof P,Knuuti J,Kolh P,Lancellotti P,Linhart A,Nihoyannopoulos P,Piepoli MF,Ponikowski P,Sirnes PA,Tamargo JL,Tendera M,Torbicki A,Wijns W,Windecker S,Kirchhof P,Blomstrom-Lundqvist C,Badano LP,Aliyev F,Bänsch D,Baumgartner H,Bsata W,Buser P,Charron P,Daubert JC,Dobreanu D,Faerestrand S,Hasdai D,Hoes AW,Le Heuzey JY,Mavrakis H,McDonagh T,Merino JL,Nawar MM,Nielsen JC,Pieske B,Poposka L,Ruschitzka F,Tendera M,Van Gelder IC,Wilson CM, 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). European heart journal. 2013 Aug; [PubMed PMID: 23801822] |
[5] | O'Gara PT,Kushner FG,Ascheim DD,Casey DE Jr,Chung MK,de Lemos JA,Ettinger SM,Fang JC,Fesmire FM,Franklin BA,Granger CB,Krumholz HM,Linderbaum JA,Morrow DA,Newby LK,Ornato JP,Ou N,Radford MJ,Tamis-Holland JE,Tommaso CL,Tracy CM,Woo YJ,Zhao DX, 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology. 2013 Jan 29; [PubMed PMID: 23256914] |
[6] | Elliott PM,Anastasakis A,Borger MA,Borggrefe M,Cecchi F,Charron P,Hagege AA,Lafont A,Limongelli G,Mahrholdt H,McKenna WJ,Mogensen J,Nihoyannopoulos P,Nistri S,Pieper PG,Pieske B,Rapezzi C,Rutten FH,Tillmanns C,Watkins H, 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). European heart journal. 2014 Oct 14; [PubMed PMID: 25173338] |
[7] | Gersh BJ,Maron BJ,Bonow RO,Dearani JA,Fifer MA,Link MS,Naidu SS,Nishimura RA,Ommen SR,Rakowski H,Seidman CE,Towbin JA,Udelson JE,Yancy CW, 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011 Dec 13; [PubMed PMID: 22068435] |
[8] | Auricchio A,Delnoy PP,Butter C,Brachmann J,Van Erven L,Spitzer S,Moccetti T,Seifert M,Markou T,Laszo K,Regoli F, Feasibility, safety, and short-term outcome of leadless ultrasound-based endocardial left ventricular resynchronization in heart failure patients: results of the wireless stimulation endocardially for CRT (WiSE-CRT) study. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2014 May; [PubMed PMID: 24497573] |
[9] | Reddy VY,Knops RE,Sperzel J,Miller MA,Petru J,Simon J,Sediva L,de Groot JR,Tjong FV,Jacobson P,Ostrosff A,Dukkipati SR,Koruth JS,Wilde AA,Kautzner J,Neuzil P, Permanent leadless cardiac pacing: results of the LEADLESS trial. Circulation. 2014 Apr 8; [PubMed PMID: 24664277] |
[10] | Knops RE,Tjong FV,Neuzil P,Sperzel J,Miller MA,Petru J,Simon J,Sediva L,de Groot JR,Dukkipati SR,Koruth JS,Wilde AA,Kautzner J,Reddy VY, Chronic performance of a leadless cardiac pacemaker: 1-year follow-up of the LEADLESS trial. Journal of the American College of Cardiology. 2015 Apr 21; [PubMed PMID: 25881930] |
[11] | Bernstein AD,Daubert JC,Fletcher RD,Hayes DL,Lüderitz B,Reynolds DW,Schoenfeld MH,Sutton R, The revised NASPE/BPEG generic code for antibradycardia, adaptive-rate, and multisite pacing. North American Society of Pacing and Electrophysiology/British Pacing and Electrophysiology Group. Pacing and clinical electrophysiology : PACE. 2002 Feb; [PubMed PMID: 11916002] |